To explore whether PCAT6 can act as a ceRNA in ovarian cancer, we combined small-RNA sequencing, bioinformatic analysis and dual-luciferase reporter assays and verified that miR-143-3p was a direct target of PCAT6. Here, PCAT6 is linked to ovarian cancer.